Liyang

Blog

What are the differences between active pharmaceutical ingredients and finished dosage forms?


  Active pharmaceutical ingredients (APIs) are the active components of drugs and cannot be used directly for clinical treatment. Pharmaceutical preparations, on the other hand, are drug formulations processed from APIs combined with excipients, designed to be administered directly to patients in various dosage forms such as tablets or injections. The key distinction lies in the fact that APIs serve as the foundational components of pharmaceutical preparations; only through appropriate formulation processes can they be transformed into safe and effective medications suitable for clinical use.

  Definition and Purpose

  Active Pharmaceutical Ingredient (API): Refers to chemically or biologically active components that possess pharmacological activity, meeting the purity standards specified in pharmacopoeias. However, these ingredients cannot be used directly as they require further processing.

  Formulation: Prepared by combining active pharmaceutical ingredients with excipients (such as diluents and disintegrants) into specific dosage forms (e.g., tablets or capsules), ready for direct administration to patients.

  Production Process

  Active Pharmaceutical Ingredient Production: Involves complex chemical or biological reactions (such as synthesis or fermentation), requiring purification to remove impurities. The processes are diverse and demand specialized equipment, while also imposing stringent environmental requirements, such as the use of high-level cleanrooms.

  Formulation Production: Primarily based on physical mixing (e.g., tableting, filling), with minimal changes to chemical structures and relatively straightforward processes. However, strict adherence to GMP standards is essential.

  Quality Control and Analysis

  Active Pharmaceutical Ingredient Analysis: Focuses on purity, chemical structure, and synthetic impurities. The analytical method is direct (e.g., HPLC), and results are reported as "percentage content."

  Formulation Analysis: It is necessary to eliminate excipient interference and incorporate formulation-specific parameters, such as dissolution and microbial limits. Results should be expressed as "percentage of labeled amount," with particular attention paid to degradation products.

Related News


Biopharmaceutical Industry: A Powerful Innovation Engine Driving Global Market Competition

The deep integration of artificial intelligence technology has transformed drug development from "searching for a needle in a haystack" to "precise navigation."


The Differences Between Intermediates, Active Pharmaceutical Ingredients (APIs), Excipients, and Preparations

Intermediate, a material generated during the active pharmaceutical ingredient (API) manufacturing process that requires further molecular transformation or purification before it can be finalized as an API.


What are the differences between active pharmaceutical ingredients and finished dosage forms?

Active pharmaceutical ingredients (APIs) are the active components of drugs and cannot be used directly for clinical treatment. Pharmaceutical preparations, on the other hand, are drug formulations made by processing APIs with excipients, ready for direct use by patients.


The method of decocting traditional Chinese medicine

First, pour the medicinal herbs into the decoction vessel and add cool water until the herbs are fully submerged. Allow them to soak for about an hour, enabling the traditional Chinese medicine to absorb moisture thoroughly and return to a fresh state. This process ensures that the active ingredients can be released more quickly and efficiently.


What are the common types of liquid formulations?

This is a common type of liquid formulation, referring to a homogeneous system in which the drug is uniformly dispersed in the solvent in molecular or ionic form.


Trends in the Pharmaceutical Industry

Breakthroughs in biotechnology and artificial intelligence are driving advancements in new drug development, paving the way for more innovative therapies and offering patients a wider range of treatment options.